QA: Checkpoint Therapeutics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651407_2022_Checkpoint_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001651407, Checkpoint Therapeutics Inc

  xvar xval
0 AssetsCurrent 55,728,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 25,982,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,805,795
9 ResearchAndDevelopmentExpense 39,881,504
10 remainder_Expenses 0
11 remainder_Revenues 485,483
12 remainder_NetIncome 63,383
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 55,728,000
1 Liabilities 25,982,000
2 Expenses 48,687,299
3 Revenues 485,483
4 StockholdersEquity 29,746,000
5 NetIncome -48,138,433
6 ComprehensiveNetIncome -48,138,433
7 BaseVar 65,473,082
8 EconomicCapitalRatiobeforeLimitedLiability 0.409
9 EconomicCapitalRatio 1.80

Edgar->Model Mapping

Feature Distribution

Change over Time